N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis

Shiho Uematsu, Yuki Goto, Takehiro Suzuki, Yukiko Sasazawa, Naoshi Dohmae, Siro Simizu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Extracellular matrix protein 1 (ECM1) is expressed in a wide variety of tissues and plays important roles in extracellular matrix formation. Additionally, ECM1 gene mutations cause lipoid proteinosis (LP), a rare skin condition of genetic origin. However, an effective therapeutic approach of LP is not established. Here, we showed that ECM1 gene mutation observed in LP patients significantly suppresses its secretion. As ECM1 has three putative N-glycosylation sites and most of mutated ECM1 observed in LP patients are defective in these N-glycosylation sites, we investigated the correlation between LP and N-glycosylation of ECM1. We identified that the Asn354 and Asn444 residues in ECM1 were N-glycosylated by mass spectrometry analysis. In addition, an N-linked glycan at Asn354 negatively regulated secretion of ECM1, contrary to LP patient-derived mutants. These results indicate that the defect of N-glycosylation in ECM1 is not involved in the aberration of secretion of LP-derived mutated ECM1.

Original languageEnglish
Pages (from-to)879-885
Number of pages7
JournalFEBS Open Bio
Volume4
DOIs
Publication statusPublished - 2014 Aug 1

Fingerprint

Glycosylation
Extracellular Matrix Proteins
Genes
Mutation
Aberrations
Extracellular Matrix
Mass spectrometry
Polysaccharides
Mass Spectrometry
Skin
Tissue

Keywords

  • Extracellular matrix protein 1
  • Lipoid proteinosis
  • N-Glycosylation
  • Secretion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis. / Uematsu, Shiho; Goto, Yuki; Suzuki, Takehiro; Sasazawa, Yukiko; Dohmae, Naoshi; Simizu, Siro.

In: FEBS Open Bio, Vol. 4, 01.08.2014, p. 879-885.

Research output: Contribution to journalArticle

Uematsu, Shiho ; Goto, Yuki ; Suzuki, Takehiro ; Sasazawa, Yukiko ; Dohmae, Naoshi ; Simizu, Siro. / N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis. In: FEBS Open Bio. 2014 ; Vol. 4. pp. 879-885.
@article{7f620b5d01e14149863169c7104f900f,
title = "N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis",
abstract = "Extracellular matrix protein 1 (ECM1) is expressed in a wide variety of tissues and plays important roles in extracellular matrix formation. Additionally, ECM1 gene mutations cause lipoid proteinosis (LP), a rare skin condition of genetic origin. However, an effective therapeutic approach of LP is not established. Here, we showed that ECM1 gene mutation observed in LP patients significantly suppresses its secretion. As ECM1 has three putative N-glycosylation sites and most of mutated ECM1 observed in LP patients are defective in these N-glycosylation sites, we investigated the correlation between LP and N-glycosylation of ECM1. We identified that the Asn354 and Asn444 residues in ECM1 were N-glycosylated by mass spectrometry analysis. In addition, an N-linked glycan at Asn354 negatively regulated secretion of ECM1, contrary to LP patient-derived mutants. These results indicate that the defect of N-glycosylation in ECM1 is not involved in the aberration of secretion of LP-derived mutated ECM1.",
keywords = "Extracellular matrix protein 1, Lipoid proteinosis, N-Glycosylation, Secretion",
author = "Shiho Uematsu and Yuki Goto and Takehiro Suzuki and Yukiko Sasazawa and Naoshi Dohmae and Siro Simizu",
year = "2014",
month = "8",
day = "1",
doi = "10.1016/j.fob.2014.10.004",
language = "English",
volume = "4",
pages = "879--885",
journal = "FEBS Open Bio",
issn = "2211-5463",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis

AU - Uematsu, Shiho

AU - Goto, Yuki

AU - Suzuki, Takehiro

AU - Sasazawa, Yukiko

AU - Dohmae, Naoshi

AU - Simizu, Siro

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Extracellular matrix protein 1 (ECM1) is expressed in a wide variety of tissues and plays important roles in extracellular matrix formation. Additionally, ECM1 gene mutations cause lipoid proteinosis (LP), a rare skin condition of genetic origin. However, an effective therapeutic approach of LP is not established. Here, we showed that ECM1 gene mutation observed in LP patients significantly suppresses its secretion. As ECM1 has three putative N-glycosylation sites and most of mutated ECM1 observed in LP patients are defective in these N-glycosylation sites, we investigated the correlation between LP and N-glycosylation of ECM1. We identified that the Asn354 and Asn444 residues in ECM1 were N-glycosylated by mass spectrometry analysis. In addition, an N-linked glycan at Asn354 negatively regulated secretion of ECM1, contrary to LP patient-derived mutants. These results indicate that the defect of N-glycosylation in ECM1 is not involved in the aberration of secretion of LP-derived mutated ECM1.

AB - Extracellular matrix protein 1 (ECM1) is expressed in a wide variety of tissues and plays important roles in extracellular matrix formation. Additionally, ECM1 gene mutations cause lipoid proteinosis (LP), a rare skin condition of genetic origin. However, an effective therapeutic approach of LP is not established. Here, we showed that ECM1 gene mutation observed in LP patients significantly suppresses its secretion. As ECM1 has three putative N-glycosylation sites and most of mutated ECM1 observed in LP patients are defective in these N-glycosylation sites, we investigated the correlation between LP and N-glycosylation of ECM1. We identified that the Asn354 and Asn444 residues in ECM1 were N-glycosylated by mass spectrometry analysis. In addition, an N-linked glycan at Asn354 negatively regulated secretion of ECM1, contrary to LP patient-derived mutants. These results indicate that the defect of N-glycosylation in ECM1 is not involved in the aberration of secretion of LP-derived mutated ECM1.

KW - Extracellular matrix protein 1

KW - Lipoid proteinosis

KW - N-Glycosylation

KW - Secretion

UR - http://www.scopus.com/inward/record.url?scp=84908506567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908506567&partnerID=8YFLogxK

U2 - 10.1016/j.fob.2014.10.004

DO - 10.1016/j.fob.2014.10.004

M3 - Article

AN - SCOPUS:84908506567

VL - 4

SP - 879

EP - 885

JO - FEBS Open Bio

JF - FEBS Open Bio

SN - 2211-5463

ER -